Munich, Germany

Annette Hüttig

This inventor holds 2 USPTO granted patents. Top assignee: Novaliq Gmbh. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annette Hüttig. Retrieved from https://idiyas.com/inventor/annette-hüttig

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Location History:

  • München, DE (2017)
  • Munich, DE (2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Annette Hüttig: Innovator in Protein Stability

Introduction

Annette Hüttig is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biochemistry, particularly in the development of stabilized protein compositions. With a total of 2 patents, her work focuses on enhancing the stability and shelf-life of bioactive polypeptides and proteins.

Latest Patents

Hüttig's latest patents include innovative compositions that utilize semifluorinated alkanes as liquid vehicles. These compositions are designed to protect polypeptides and proteins from degradation and aggregation. The applications of her inventions are versatile, allowing for topical administration, such as into the eye, or through parenteral injection, including subcutaneous or intramuscular routes.

Career Highlights

Annette Hüttig is currently associated with Novaliq GmbH, where she continues to advance her research in protein stability. Her work has garnered attention for its potential applications in various medical fields, particularly in drug delivery systems.

Collaborations

Hüttig collaborates with notable colleagues, including Bernhard Günther and Bastian Theisinger, to further enhance the impact of her research and innovations.

Conclusion

Annette Hüttig's contributions to the field of biochemistry through her patented innovations demonstrate her commitment to improving protein stability and efficacy. Her work holds promise for advancements in medical applications and drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…